4//SEC Filing
BATOR MICHAEL G. 4
Accession 0001104659-23-126429
CIK 0001175151other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:33 PM ET
Size
8.1 KB
Accession
0001104659-23-126429
Insider Transaction Report
Form 4
BATOR MICHAEL G.
Director
Transactions
- Purchase
Common Stock Warrant (Right to Buy)
2023-12-13+13,157→ 13,157 totalExercise: $2.00From: 2023-12-13Exp: 2028-12-13→ Common Stock (13,157 underlying) - Purchase
Common Stock
2023-12-13$1.33/sh+37,594$50,000→ 125,394 total
Footnotes (2)
- [F1]These securities were purchased by the reporting person in the registered direct offering of CytoSorbents Corporation (the "Company"), which closed on December 13, 2023. In the offering, each share of common stock, par value $0.001 per share (the "Common Stock") of the Company was purchased together with an accompanying warrant to purchase up to 0.35 shares of Common Stock, at a combined offering price of $1.33 per share of Common Stock and accompanying warrant.
- [F2]Includes (a) the following restricted stock units ("RSUs") which will vest upon a "Change of Control" of the Company, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (i) 3,300 RSUs granted on March 15, 2018, (ii) 6,000 RSUs granted on February 24, 2017, and (iii) 60,000 RSUs granted on June 7, 2016, and (b) 56,094 shares of Common Stock owned by the reporting person.
Documents
Issuer
Cytosorbents Corp
CIK 0001175151
Entity typeother
Related Parties
1- filerCIK 0001647591
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 4:33 PM ET
- Size
- 8.1 KB